| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||

| Delaware | 56-1546236 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | |||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock (par value of $0.01 per share) | SNPS | Nasdaq Global Select Market | ||||||
| Large accelerated filer | ý | Accelerated Filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ¨ | Smaller reporting company | ☐ | |||||||||||||||||
| Emerging growth company | ☐ | |||||||||||||||||||
| Page | ||||||||
| PART I. | ||||||||
| Item 1. | Financial Statements (Unaudited) | |||||||
| Item 2. | ||||||||
| Item 3. | ||||||||
| Item 4. | ||||||||
| PART II. | ||||||||
| Item 1. | ||||||||
| Item 1A. | ||||||||
| Item 2. | ||||||||
| Item 5. | ||||||||
| Item 6. | ||||||||
| Item 1. | Financial Statements | |||||||
| April 30, 2026 | October 31, 2025 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 2,412,472 | $ | 2,888,030 | |||||||
| Short-term investments | 71,966 | 72,929 | |||||||||
| Total cash, cash equivalents and short-term investments | 2,484,438 | 2,960,959 | |||||||||
| Accounts receivable, net | 1,267,305 | 1,505,427 | |||||||||
| Inventories | 441,836 | 365,190 | |||||||||
| Prepaid and other current assets | 1,195,391 | 1,180,526 | |||||||||
Current assets held for sale | 48,248 | — | |||||||||
| Total current assets | 5,437,218 | 6,012,102 | |||||||||
| Property and equipment, net | 714,744 | 696,693 | |||||||||
| Operating lease right-of-use assets, net | 697,112 | 702,008 | |||||||||
| Goodwill | 26,853,807 | 26,899,215 | |||||||||
| Intangible assets, net | 11,875,418 | 12,679,591 | |||||||||
| Deferred income taxes | 113,642 | 112,159 | |||||||||
| Other long-term assets | 1,197,086 | 1,122,693 | |||||||||
| Total assets | $ | 46,889,027 | $ | 48,224,461 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable and accrued liabilities | $ | 1,185,204 | $ | 1,326,211 | |||||||
| Operating lease liabilities | 135,523 | 128,205 | |||||||||
| Deferred revenue | 2,419,876 | 2,245,961 | |||||||||
| Short-term debt | 22,117 | 22,117 | |||||||||
Current liabilities held for sale | 27,912 | — | |||||||||
| Total current liabilities | 3,790,632 | 3,722,494 | |||||||||
| Long-term operating lease liabilities | 670,475 | 680,698 | |||||||||
| Long-term deferred revenue | 389,419 | 382,557 | |||||||||
| Long-term debt | 10,013,845 | 13,462,398 | |||||||||
| Other long-term liabilities | 1,547,591 | 1,649,299 | |||||||||
| Total liabilities | 16,411,962 | 19,897,446 | |||||||||
| Stockholders’ equity: | |||||||||||
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding | — | — | |||||||||
Common stock, $0.01 par value: 400,000 shares authorized; 191,444 and 185,994 shares outstanding, respectively | 1,928 | 1,860 | |||||||||
| Capital in excess of par value | 20,565,562 | 18,640,947 | |||||||||
| Retained earnings | 10,397,550 | 10,315,487 | |||||||||
Treasury stock, at cost: 593 and 1,222 shares, respectively | (242,827) | (398,278) | |||||||||
| Accumulated other comprehensive loss | (244,082) | (232,414) | |||||||||
| Total Synopsys stockholders’ equity | 30,478,131 | 28,327,602 | |||||||||
| Non-controlling interest | (1,066) | (587) | |||||||||
| Total stockholders’ equity | 30,477,065 | 28,327,015 | |||||||||
Total liabilities and stockholders’ equity | $ | 46,889,027 | $ | 48,224,461 | |||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenue: | |||||||||||||||||||||||
| Time-based products | $ | 945,624 | $ | 828,326 | $ | 1,897,165 | $ | 1,656,564 | |||||||||||||||
| Upfront products | 546,252 | 510,676 | 1,287,782 | 878,800 | |||||||||||||||||||
| Total products revenue | 1,491,876 | 1,339,002 | 3,184,947 | 2,535,364 | |||||||||||||||||||
| Maintenance and service | 784,109 | 265,264 | 1,499,836 | 524,217 | |||||||||||||||||||
| Total revenue | 2,275,985 | 1,604,266 | 4,684,783 | 3,059,581 | |||||||||||||||||||
| Cost of revenue: | |||||||||||||||||||||||
| Products | 232,897 | 216,216 | 475,299 | 385,058 | |||||||||||||||||||
| Maintenance and service | 148,597 | 94,471 | 295,335 | 187,008 | |||||||||||||||||||
Amortization of acquired intangible assets | 248,356 | 7,660 | 496,598 | 16,256 | |||||||||||||||||||
| Total cost of revenue | 629,850 | 318,347 | 1,267,232 | 588,322 | |||||||||||||||||||
| Gross margin | 1,646,135 | 1,285,919 | 3,417,551 | 2,471,259 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 700,124 | 553,979 | 1,415,112 | 1,107,195 | |||||||||||||||||||
| Sales and marketing | 381,998 | 215,021 | 778,373 | 424,220 | |||||||||||||||||||
| General and administrative | 172,418 | 136,497 | 355,150 | 303,583 | |||||||||||||||||||
Amortization of acquired intangible assets | 155,275 | 3,996 | 311,268 | 7,996 | |||||||||||||||||||
| Restructuring charges | 115,894 | — | 234,176 | — | |||||||||||||||||||
| Total operating expenses | 1,525,709 | 909,493 | 3,094,079 | 1,842,994 | |||||||||||||||||||
| Operating income | 120,426 | 376,426 | 323,472 | 628,265 | |||||||||||||||||||
Interest expense | (133,364) | (94,336) | (296,079) | (105,475) | |||||||||||||||||||
Other income (expense), net | 32,214 | 114,101 | 70,936 | 164,518 | |||||||||||||||||||
| Income before income taxes | 19,276 | 396,191 | 98,329 | 687,308 | |||||||||||||||||||
| Provision for income taxes | 2,408 | 47,181 | 16,745 | 40,887 | |||||||||||||||||||
Net income from continuing operations | 16,868 | 349,010 | 81,584 | 646,421 | |||||||||||||||||||
| Loss from discontinued operations, net of income taxes | — | (3,900) | — | (3,900) | |||||||||||||||||||
Net income | 16,868 | 345,110 | 81,584 | 642,521 | |||||||||||||||||||
Less: Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest | (237) | (222) | (479) | 1,506 | |||||||||||||||||||
| Net income attributed to Synopsys | $ | 17,105 | $ | 345,332 | $ | 82,063 | $ | 641,015 | |||||||||||||||
| Net income (loss) attributed to Synopsys: | |||||||||||||||||||||||
Continuing operations | $ | 17,105 | $ | 349,232 | $ | 82,063 | $ | 644,915 | |||||||||||||||
Discontinued operations | — | (3,900) | — | (3,900) | |||||||||||||||||||
Net income | $ | 17,105 | $ | 345,332 | $ | 82,063 | $ | 641,015 | |||||||||||||||
| Net income (loss) per share attributed to Synopsys - basic: | |||||||||||||||||||||||
Continuing operations | $ | 0.09 | $ | 2.25 | $ | 0.43 | $ | 4.17 | |||||||||||||||
Discontinued operations | — | (0.02) | — | (0.03) | |||||||||||||||||||
| Basic net income per share | $ | 0.09 | $ | 2.23 | $ | 0.43 | $ | 4.14 | |||||||||||||||
| Net income (loss) per share attributed to Synopsys - diluted: | |||||||||||||||||||||||
Continuing operations | $ | 0.09 | $ | 2.24 | $ | 0.43 | $ | 4.13 | |||||||||||||||
Discontinued operations | — | (0.03) | — | (0.03) | |||||||||||||||||||
| Diluted net income per share | $ | 0.09 | $ | 2.21 | $ | 0.43 | $ | 4.10 | |||||||||||||||
| Shares used in computing per share amounts: | |||||||||||||||||||||||
| Basic | 191,464 | 154,927 | 190,513 | 154,666 | |||||||||||||||||||
| Diluted | 192,144 | 156,088 | 191,580 | 156,218 | |||||||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net income | $ | 16,868 | $ | 345,110 | $ | 81,584 | $ | 642,521 | |||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||||||||
| Change in foreign currency translation adjustment | (37,947) | 44,764 | 586 | 16,127 | |||||||||||||||||||
Change in unrealized gains (losses) on available-for-sale securities, net of tax of $0 for periods presented | (281) | 52 | (207) | 9 | |||||||||||||||||||
| Cash flow hedges: | |||||||||||||||||||||||
Deferred gains (losses), net of tax of $1,789 and $5,332 for the three and six months ended April 30, 2026, respectively, and of $10,507 and $22,002 for each of the same periods in fiscal 2025, respectively | (5,763) | (45,708) | (17,299) | (82,155) | |||||||||||||||||||
Reclassification adjustment on deferred (gains) losses included in net income, net of tax of $(1,350) and $(2,003) for the three and six months ended April 30, 2026, respectively, and of $(783) and $(2,186) for each of the same periods in fiscal 2025, respectively | 3,592 | 2,675 | 5,252 | 6,263 | |||||||||||||||||||
| Other comprehensive income (loss), net of tax effects | (40,399) | 1,783 | (11,668) | (59,756) | |||||||||||||||||||
| Comprehensive income (loss) | (23,531) | 346,893 | 69,916 | 582,765 | |||||||||||||||||||
| Less: Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest | (237) | (222) | (479) | 1,506 | |||||||||||||||||||
| Comprehensive income (loss) attributed to Synopsys | $ | (23,294) | $ | 347,115 | $ | 70,395 | $ | 581,259 | |||||||||||||||
| Capital in Excess of Par Value | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Synopsys Stockholders’ Equity | Non-controlling Interest | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 31, 2026 | 191,449 | $ | 1,915 | $ | 20,562,001 | $ | 10,380,445 | $ | (191,851) | $ | (203,683) | $ | 30,548,827 | $ | (829) | $ | 30,547,998 | ||||||||||||||||||||||||||||||||||||
| Net income | 17,105 | 17,105 | (237) | 16,868 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax effects | (40,399) | (40,399) | (40,399) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of treasury stock | (640) | 6 | (6) | (262,500) | (262,500) | (262,500) | |||||||||||||||||||||||||||||||||||||||||||||||
| Equity forward contract, net | (37,500) | (37,500) | (37,500) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued, net of shares withheld for employee taxes | 635 | 7 | (181,236) | 211,524 | 30,295 | 30,295 | |||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 222,303 | 222,303 | 222,303 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at April 30, 2026 | 191,444 | $ | 1,928 | $ | 20,565,562 | $ | 10,397,550 | $ | (242,827) | $ | (244,082) | $ | 30,478,131 | $ | (1,066) | $ | 30,477,065 | ||||||||||||||||||||||||||||||||||||
Balance at October 31, 2025 | 185,994 | $ | 1,860 | $ | 18,640,947 | $ | 10,315,487 | $ | (398,278) | $ | (232,414) | $ | 28,327,602 | $ | (587) | $ | 28,327,015 | ||||||||||||||||||||||||||||||||||||
| Net income | 82,063 | 82,063 | (479) | 81,584 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax effects | (11,668) | (11,668) | (11,668) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of treasury stock | (640) | 6 | (6) | (262,500) | (262,500) | (262,500) | |||||||||||||||||||||||||||||||||||||||||||||||
| Equity forward contract, net | (37,500) | (37,500) | (37,500) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for private placement | 4,822 | 48 | 1,999,952 | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued for prior acquisition | 1 | 1 | 189 | 478 | 668 | 668 | |||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued, net of shares withheld for employee taxes | 1,267 | 13 | (519,047) | 417,473 | (101,561) | (101,561) | |||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 481,027 | 481,027 | 481,027 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at April 30, 2026 | 191,444 | $ | 1,928 | $ | 20,565,562 | $ | 10,397,550 | $ | (242,827) | $ | (244,082) | $ | 30,478,131 | $ | (1,066) | $ | 30,477,065 | ||||||||||||||||||||||||||||||||||||
| Capital in Excess of Par Value | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Synopsys Stockholders’ Equity | Non-controlling Interest | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 31, 2025 | 154,618 | $ | 1,547 | $ | 1,127,181 | $ | 9,278,950 | $ | (860,967) | $ | (241,919) | $ | 9,304,792 | $ | 109 | $ | 9,304,901 | ||||||||||||||||||||||||||||||||||||
| Net income | 345,332 | 345,332 | (222) | 345,110 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax effects | 1,783 | 1,783 | 1,783 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued, net of shares withheld for employee taxes | 528 | 5 | (109,883) | 171,966 | 62,088 | 62,088 | |||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 201,723 | 201,723 | 201,723 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at April 30, 2025 | 155,146 | $ | 1,552 | $ | 1,219,021 | $ | 9,624,282 | $ | (689,001) | $ | (240,136) | $ | 9,915,718 | $ | (113) | $ | 9,915,605 | ||||||||||||||||||||||||||||||||||||
Balance at October 31, 2024 | 154,112 | $ | 1,541 | $ | 1,211,206 | $ | 8,984,105 | $ | (1,025,770) | $ | (180,380) | $ | 8,990,702 | $ | 2,504 | $ | 8,993,206 | ||||||||||||||||||||||||||||||||||||
| Net income | 641,015 | 641,015 | 2,344 | 643,359 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax effects | (59,756) | (59,756) | (59,756) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issued, net of shares withheld for employee taxes | 1,034 | 11 | (385,296) | 336,769 | (48,516) | (48,516) | |||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 387,477 | 387,477 | 709 | 388,186 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustments for redeemable non-controlling interest | (838) | (838) | (838) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Deconsolidation of non-controlling interest upon the sale of subsidiary | 5,634 | 5,634 | (5,670) | (36) | |||||||||||||||||||||||||||||||||||||||||||||||||
Balance at April 30, 2025 | 155,146 | $ | 1,552 | $ | 1,219,021 | $ | 9,624,282 | $ | (689,001) | $ | (240,136) | $ | 9,915,718 | $ | (113) | $ | 9,915,605 | ||||||||||||||||||||||||||||||||||||
| Six Months Ended April 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 81,584 | $ | 642,521 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Amortization and depreciation | 907,177 | 96,838 | |||||||||
| Reduction of operating lease right-of-use assets | 72,852 | 51,728 | |||||||||
| Amortization of capitalized costs to obtain revenue contracts | 41,158 | 25,405 | |||||||||
| Stock-based compensation | 481,027 | 388,186 | |||||||||
| Allowance for credit losses | 14,842 | 15,940 | |||||||||
| Loss on sale of strategic investments | — | 2,435 | |||||||||
Gain on sale of building | — | (51,385) | |||||||||
Loss on divestitures, net of transaction costs | — | 8,299 | |||||||||
Amortization of bridge financing costs | — | 40,411 | |||||||||
Amortization of debt issuance costs | 16,903 | 2,348 | |||||||||
| Deferred income taxes | (121,045) | (237,170) | |||||||||
| Other | (153) | (181) | |||||||||
Net changes in operating assets and liabilities, net of effects from acquisitions and dispositions: | |||||||||||
| Accounts receivable | 234,512 | (74,098) | |||||||||
| Inventories | (85,832) | (39,766) | |||||||||
| Prepaid and other current assets | 44,649 | (140,472) | |||||||||
| Other long-term assets | (87,060) | (36,058) | |||||||||
| Accounts payable and accrued liabilities | (114,629) | (242,529) | |||||||||
| Operating lease liabilities | (74,166) | (48,617) | |||||||||
| Income taxes | (122,420) | (36,870) | |||||||||
| Deferred revenue | 196,367 | (37,412) | |||||||||
Unrealized loss on settlement of interest rate treasury lock | — | (121,643) | |||||||||
| Net cash provided by operating activities | 1,485,766 | 207,910 | |||||||||
| Cash flows from investing activities: | |||||||||||
Proceeds from maturities of short-term investments | 11,180 | 35,461 | |||||||||
Proceeds from sales of short-term investments | 3,656 | 22,015 | |||||||||
| Purchases of short-term investments | (13,903) | (47,558) | |||||||||
Purchases of strategic investments | (781) | (3,368) | |||||||||
| Purchases of property and equipment, net | (89,518) | (96,303) | |||||||||
Proceeds from sale of building | — | 74,279 | |||||||||
Proceeds from business divestiture, net of cash divested | — | 70,082 | |||||||||
| Other | — | (611) | |||||||||
| Net cash provided by (used in) investing activities | (89,366) | 53,997 | |||||||||
| Cash flows from financing activities: | |||||||||||
Proceeds from debt, net of issuance costs | — | 10,034,464 | |||||||||
Repayment of debt | (3,462,369) | (1,289) | |||||||||
| Issuances of common stock | 116,136 | 118,308 | |||||||||
| Payments for taxes related to net share settlement of equity awards | (217,884) | (166,872) | |||||||||
Common stock issuance for private placement | 2,000,000 | — | |||||||||
| Purchase of equity forward contract | (37,500) | — | |||||||||
| Purchases of treasury stock | (262,500) | — | |||||||||
Redemption of redeemable non-controlling interest | — | (30,000) | |||||||||
| Net cash provided by (used in) financing activities | (1,864,117) | 9,954,611 | |||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (9,247) | 8,186 | |||||||||
| Net change in cash, cash equivalents and restricted cash | (476,964) | 10,224,704 | |||||||||
| Cash, cash equivalents and restricted cash, beginning of year | 2,893,721 | 3,898,729 | |||||||||
| Cash, cash equivalents and restricted cash, end of period | $ | 2,416,757 | $ | 14,123,433 | |||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||
2025 | 2025 | ||||||||||
| (in thousands) | |||||||||||
Pro forma total revenue | $ | 2,157,992 | $ | 4,375,675 | |||||||
Pro forma net income | $ | 18,614 | $ | 74,980 | |||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| EDA | 51.0 | % | 66.9 | % | 48.3 | % | 67.1 | % | |||||||||||||||
| Design IP | 20.0 | % | 30.0 | % | 18.4 | % | 30.0 | % | |||||||||||||||
| Ansys | 28.7 | % | — | % | 32.8 | % | — | % | |||||||||||||||
| Other | 0.3 | % | 3.1 | % | 0.5 | % | 2.9 | % | |||||||||||||||
| Total | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
| As of | |||||||||||
| April 30, 2026 | October 31, 2025 | ||||||||||
| (in thousands) | |||||||||||
| Contract assets, net | $ | 1,119,650 | $ | 1,222,029 | |||||||
| Unbilled receivables | $ | 28,620 | $ | 45,528 | |||||||
| Deferred revenue | $ | 2,809,295 | $ | 2,628,518 | |||||||
| (in thousands) | |||||
Balance at October 31, 2025 | $ | 26,899,215 | |||
| Adjustments | (43,278) | ||||
| Effect of foreign currency translation | (2,130) | ||||
Balance at April 30, 2026 | $ | 26,853,807 | |||
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||
| (in thousands) | |||||||||||||||||
| Core/developed technology | $ | 7,314,600 | $ | 1,317,353 | $ | 5,997,247 | |||||||||||
| Customer relationships | 5,415,568 | 718,972 | 4,696,596 | ||||||||||||||
| Contract rights intangible | 612,855 | 348,636 | 264,219 | ||||||||||||||
| Trademarks and trade names | 962,925 | 45,569 | 917,356 | ||||||||||||||
| Total | $ | 14,305,948 | $ | 2,430,530 | $ | 11,875,418 | |||||||||||
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||
| (in thousands) | |||||||||||||||||
| Core/developed technology | $ | 7,309,753 | $ | 929,901 | $ | 6,379,852 | |||||||||||
| Customer relationships | 5,415,558 | 428,377 | 4,987,181 | ||||||||||||||
| Contract rights intangible | 614,358 | 239,808 | 374,550 | ||||||||||||||
| Trademarks and trade names | 962,925 | 24,917 | 938,008 | ||||||||||||||
| Total | $ | 14,302,594 | $ | 1,623,003 | $ | 12,679,591 | |||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Core/developed technology | $ | 193,619 | $ | 7,337 | $ | 387,142 | $ | 15,526 | |||||||||||||||
| Customer relationships | 144,949 | 3,993 | 290,616 | 7,989 | |||||||||||||||||||
| Contract rights intangible | 54,737 | 323 | 109,456 | 730 | |||||||||||||||||||
| Trademarks and trade names | 10,326 | 3 | 20,652 | 7 | |||||||||||||||||||
| Total | $ | 403,631 | $ | 11,656 | $ | 807,866 | $ | 24,252 | |||||||||||||||
| Fiscal year | (in thousands) | ||||
| Remainder of fiscal 2026 | $ | 805,653 | |||
| 2027 | 1,545,111 | ||||
| 2028 | 1,384,601 | ||||
| 2029 | 1,381,906 | ||||
| 2030 | 1,376,058 | ||||
| 2031 and thereafter | 5,382,089 | ||||
| Total | $ | 11,875,418 | |||
| As of | |||||||||||
| April 30, 2026 | October 31, 2025 | ||||||||||
| (in thousands) | |||||||||||
| Accounts payable and accrued liabilities: | |||||||||||
| Payroll and related benefits | $ | 701,291 | $ | 822,575 | |||||||
| Accounts payable | 179,257 | 164,766 | |||||||||
| Accrued income taxes | 45,020 | 94,664 | |||||||||
Interest payable | 42,603 | 49,826 | |||||||||
| Other accrued liabilities | 217,033 | 194,380 | |||||||||
| Total | $ | 1,185,204 | $ | 1,326,211 | |||||||
| Other long-term liabilities: | |||||||||||
Deferred tax liability | $ | 877,749 | $ | 1,001,070 | |||||||
| Deferred compensation plan liabilities | 468,523 | 447,232 | |||||||||
| Other | 201,319 | 200,997 | |||||||||
| Total | $ | 1,547,591 | $ | 1,649,299 | |||||||
| (in thousands) | |||||
| Assets: | |||||
| Accounts receivable, net | $ | 541 | |||
| Inventories | 72 | ||||
Prepaid and other assets | 5,623 | ||||
| Property and equipment, net | 2,127 | ||||
| Operating lease right-of-use assets, net | 1,870 | ||||
| Goodwill | 38,015 | ||||
| Total current assets held for sale | $ | 48,248 | |||
| Liabilities: | |||||
| Accounts payable and accrued liabilities | $ | 1,841 | |||
| Operating lease liabilities | 1,744 | ||||
| Deferred revenue | 24,327 | ||||
| Total current liabilities held for sale | $ | 27,912 | |||
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses Less Than 12 Continuous Months | Gross Unrealized Losses 12 Continuous Months or Longer | Estimated Fair Value(1) | |||||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||||||||
| Cash equivalents: | |||||||||||||||||||||||||||||
| Money market funds | $ | 196,433 | $ | — | $ | — | $ | — | $ | 196,433 | |||||||||||||||||||
| U.S. Treasury, agency & T-bills | 1,645 | — | — | — | 1,645 | ||||||||||||||||||||||||
| Total: | $ | 198,078 | $ | — | $ | — | $ | — | $ | 198,078 | |||||||||||||||||||
| Short-term investments: | |||||||||||||||||||||||||||||
| U.S. Treasury, agency & T-bills | $ | 5,656 | $ | 5 | $ | — | $ | — | $ | 5,661 | |||||||||||||||||||
| Municipal bonds | 23,442 | 23 | (51) | — | 23,414 | ||||||||||||||||||||||||
| Corporate debt securities | 42,697 | 98 | (81) | — | 42,714 | ||||||||||||||||||||||||
| Other | 177 | — | — | — | 177 | ||||||||||||||||||||||||
| Total: | $ | 71,972 | $ | 126 | $ | (132) | $ | — | $ | 71,966 | |||||||||||||||||||
| Amortized Cost | Fair Value | ||||||||||
| (in thousands) | |||||||||||
1 year or less | $ | 28,479 | $ | 28,515 | |||||||
| 1-5 years | 43,493 | 43,451 | |||||||||
| Total | $ | 71,972 | $ | 71,966 | |||||||
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses Less Than 12 Continuous Months | Gross Unrealized Losses 12 Continuous Months or Longer | Estimated Fair Value(1) | |||||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||||||||
| Cash equivalents: | |||||||||||||||||||||||||||||
| Money market funds | $ | 52,978 | $ | — | $ | — | $ | — | $ | 52,978 | |||||||||||||||||||
| Total: | $ | 52,978 | $ | — | $ | — | $ | — | $ | 52,978 | |||||||||||||||||||
| Short-term investments: | |||||||||||||||||||||||||||||
| U.S. Treasury, agency & T-bills | $ | 6,661 | $ | 19 | $ | — | $ | — | $ | 6,680 | |||||||||||||||||||
| Municipal bonds | 22,004 | 61 | — | — | 22,065 | ||||||||||||||||||||||||
| Corporate debt securities | 43,878 | 139 | (18) | — | 43,999 | ||||||||||||||||||||||||
| Other | 185 | — | — | — | 185 | ||||||||||||||||||||||||
| Total: | $ | 72,728 | $ | 219 | $ | (18) | $ | — | $ | 72,929 | |||||||||||||||||||
| As of | |||||||||||
| April 30, 2026 | October 31, 2025 | ||||||||||
| (in thousands) | |||||||||||
| Cash and cash equivalents | $ | 2,412,472 | $ | 2,888,030 | |||||||
| Restricted cash included in prepaid and other current assets | 3,270 | 4,680 | |||||||||
| Restricted cash included in other long-term assets | 1,015 | 1,011 | |||||||||
Cash, cash equivalents and restricted cash | $ | 2,416,757 | $ | 2,893,721 | |||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
Gains (losses) recorded in other income (expense), net | $ | (7,790) | $ | 11,186 | $ | (12,087) | $ | 6,765 | |||||||||||||||
| As of | |||||||||||
| April 30, 2026 | October 31, 2025 | ||||||||||
| (in thousands) | |||||||||||
| Total gross notional amounts | $ | 1,780,365 | $ | 1,587,863 | |||||||
| Net fair value | $ | (23,220) | $ | (1,234) | |||||||
| Fair values of derivative instruments designated as hedging instruments | Fair values of derivative instruments not designated as hedging instruments | ||||||||||
| (in thousands) | |||||||||||
Balance at April 30, 2026 | |||||||||||
| Other current assets | $ | 15,619 | $ | 184 | |||||||
| Accrued liabilities | $ | 38,174 | $ | 849 | |||||||
Balance at October 31, 2025 | |||||||||||
| Other current assets | $ | 8,598 | $ | 265 | |||||||
| Accrued liabilities | $ | 9,504 | $ | 593 | |||||||
| Location of gains (losses) recognized in OCI on derivatives | Amount of gains (losses) recognized in OCI on derivatives (effective portion) | Location of gains (losses) reclassified from OCI | Amount of gains (losses) reclassified from OCI (effective portion) | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Three months ended April 30, 2026 | |||||||||||||||||||||||
| Foreign exchange contracts | Revenue | $ | 7,720 | Revenue | $ | 1,085 | |||||||||||||||||
| Foreign exchange contracts | Operating expenses | (13,483) | Operating expenses | (3,346) | |||||||||||||||||||
| Interest rate contracts | Interest expense | — | Interest expenses | (1,331) | |||||||||||||||||||
| Total | $ | (5,763) | $ | (3,592) | |||||||||||||||||||
| Three months ended April 30, 2025 | |||||||||||||||||||||||
| Foreign exchange contracts | Revenue | $ | 12,689 | Revenue | $ | 1,282 | |||||||||||||||||
| Foreign exchange contracts | Operating expenses | 14,749 | Operating expenses | (3,069) | |||||||||||||||||||
| Interest rate contracts | Interest expense | (73,146) | Interest expense | (888) | |||||||||||||||||||
| Total | $ | (45,708) | $ | (2,675) | |||||||||||||||||||
| Six months ended April 30, 2026 | |||||||||||||||||||||||
| Foreign exchange contracts | Revenue | $ | 10,647 | Revenue | $ | 2,275 | |||||||||||||||||
| Foreign exchange contracts | Operating expenses | (27,946) | Operating expenses | (4,864) | |||||||||||||||||||
| Interest rate contracts | Interest expense | — | Interest expenses | (2,663) | |||||||||||||||||||
| Total | $ | (17,299) | $ | (5,252) | |||||||||||||||||||
| Six months ended April 30, 2025 | |||||||||||||||||||||||
| Foreign exchange contracts | Revenue | $ | 13,203 | Revenue | $ | 280 | |||||||||||||||||
| Foreign exchange contracts | Operating expenses | (2,142) | Operating expenses | (5,655) | |||||||||||||||||||
| Interest rate contracts | Interest expense | (93,216) | Interest expense | (888) | |||||||||||||||||||
| Total | $ | (82,155) | $ | (6,263) | |||||||||||||||||||
| Fair Value Measurement Using | |||||||||||||||||||||||
| Description | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Cash equivalents: | |||||||||||||||||||||||
| Money market funds | $ | 196,433 | $ | 196,433 | $ | — | $ | — | |||||||||||||||
| U.S. Treasury, agency & T-bills | 1,645 | — | 1,645 | — | |||||||||||||||||||
| Short-term investments: | |||||||||||||||||||||||
| U.S. Treasury, agency & T-bills | 5,661 | — | 5,661 | — | |||||||||||||||||||
| Municipal bonds | 23,414 | — | 23,414 | — | |||||||||||||||||||
| Corporate debt securities | 42,714 | — | 42,714 | — | |||||||||||||||||||
| Other | 177 | — | 177 | — | |||||||||||||||||||
| Prepaid and other current assets: | |||||||||||||||||||||||
| Foreign currency derivative contracts | 15,803 | — | 15,803 | — | |||||||||||||||||||
| Contingent consideration receivable | 22,202 | — | — | 22,202 | |||||||||||||||||||
| Other long-term assets: | |||||||||||||||||||||||
| Deferred compensation plan assets | 468,523 | 468,523 | — | — | |||||||||||||||||||
Marketable equity securities | 515 | 515 | — | — | |||||||||||||||||||
| Total assets | $ | 777,087 | $ | 665,471 | $ | 89,414 | $ | 22,202 | |||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Accounts payable and accrued liabilities: | |||||||||||||||||||||||
| Foreign currency derivative contracts | $ | 39,023 | $ | — | $ | 39,023 | $ | — | |||||||||||||||
| Other long-term liabilities: | |||||||||||||||||||||||
| Deferred compensation plan liabilities | 468,523 | 468,523 | — | — | |||||||||||||||||||
| Total liabilities | $ | 507,546 | $ | 468,523 | $ | 39,023 | $ | — | |||||||||||||||
| Fair Value Measurement Using | |||||||||||||||||||||||
| Description | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Cash equivalents: | |||||||||||||||||||||||
| Money market funds | $ | 52,978 | $ | 52,978 | $ | — | $ | — | |||||||||||||||
| Short-term investments: | |||||||||||||||||||||||
| U.S. Treasury, agency & T-bills | 6,680 | — | 6,680 | — | |||||||||||||||||||
| Municipal bonds | 22,065 | — | 22,065 | — | |||||||||||||||||||
| Corporate debt securities | 43,999 | — | 43,999 | — | |||||||||||||||||||
| Other | 185 | — | 185 | — | |||||||||||||||||||
| Prepaid and other current assets: | |||||||||||||||||||||||
| Foreign currency derivative contracts | 8,863 | — | 8,863 | — | |||||||||||||||||||
| Contingent consideration receivable | 22,202 | — | — | 22,202 | |||||||||||||||||||
| Other long-term assets: | |||||||||||||||||||||||
| Deferred compensation plan assets | 447,232 | 447,232 | — | — | |||||||||||||||||||
Marketable equity securities | 785 | 785 | — | — | |||||||||||||||||||
| Total assets | $ | 604,989 | $ | 500,995 | $ | 81,792 | $ | 22,202 | |||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Accounts payable and accrued liabilities: | |||||||||||||||||||||||
| Foreign currency derivative contracts | $ | 10,097 | $ | — | $ | 10,097 | $ | — | |||||||||||||||
| Other long-term liabilities: | |||||||||||||||||||||||
| Deferred compensation plan liabilities | 447,232 | 447,232 | — | — | |||||||||||||||||||
| Total liabilities | $ | 457,329 | $ | 447,232 | $ | 10,097 | $ | — | |||||||||||||||
| Effective Interest Rate | Amount (in thousands) | |||||||||||||
Fixed-rate 4.550% Senior Notes due on April 1, 2027 | 4.840 | % | $ | 1,000,000 | ||||||||||
Fixed-rate 4.650% Senior Notes due on April 1, 2028 | 4.850 | % | 1,000,000 | |||||||||||
Fixed-rate 4.850% Senior Notes due on April 1, 2030 | 4.980 | % | 2,000,000 | |||||||||||
Fixed-rate 5.000% Senior Notes due on April 1, 2032 | 5.150 | % | 1,500,000 | |||||||||||
Fixed-rate 5.150% Senior Notes due on April 1, 2035 | 5.270 | % | 2,400,000 | |||||||||||
Fixed-rate 5.700% Senior Notes due on April 1, 2055 | 5.800 | % | 2,100,000 | |||||||||||
| Total | 10,000,000 | |||||||||||||
Unamortized discount and issuance costs | (75,729) | |||||||||||||
Total Senior Notes | 9,924,271 | |||||||||||||
Deferred payment on settlement of interest rate treasury lock | 99,526 | |||||||||||||
Other borrowings | 12,165 | |||||||||||||
Total | $ | 10,035,962 | ||||||||||||
Reported as: | ||||||||||||||
Short-term debt | $ | 22,117 | ||||||||||||
| Long-term debt | 10,013,845 | |||||||||||||
| Total | $ | 10,035,962 | ||||||||||||
Principal Payments | |||||
| Fiscal year | (in thousands) | ||||
| Remainder of fiscal 2026 | $ | 12,411 | |||
| 2027 | 1,024,820 | ||||
| 2028 | 1,024,820 | ||||
| 2029 | 24,820 | ||||
| 2030 | 2,024,820 | ||||
| 2031 and thereafter | 6,000,000 | ||||
| Total | $ | 10,111,691 | |||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
Operating lease expense (1) | $ | 37,244 | $ | 26,063 | $ | 74,451 | $ | 51,115 | |||||||||||||||
Variable lease expense (2) | 12,105 | 6,797 | 22,622 | 13,557 | |||||||||||||||||||
| Total lease expense | $ | 49,349 | $ | 32,860 | $ | 97,073 | $ | 64,672 | |||||||||||||||
| Six Months Ended April 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| (in thousands) | |||||||||||
| Cash paid for amounts included in the measurement of operating lease liabilities | $ | 69,942 | $ | 52,374 | |||||||
| ROU assets obtained in exchange for operating lease liabilities | $ | 70,891 | $ | 70,957 | |||||||
| As of | |||||||||||
| April 30, 2026 | October 31, 2025 | ||||||||||
| Weighted-average remaining lease term (in years) | 6.54 | 6.88 | |||||||||
| Weighted-average discount rate | 3.46 | % | 3.40 | % | |||||||
| Lease Payments | |||||
| Fiscal year | (in thousands) | ||||
| Remainder of fiscal 2026 | $ | 76,968 | |||
| 2027 | 166,029 | ||||
| 2028 | 152,626 | ||||
| 2029 | 140,668 | ||||
| 2030 | 111,140 | ||||
| 2031 and thereafter | 256,469 | ||||
Total future minimum lease payments | 903,900 | ||||
| Less: Imputed interest | 97,902 | ||||
Total lease liabilities | $ | 805,998 | |||
| Lease Receipts | |||||
| Fiscal year | (in thousands) | ||||
| Remainder of fiscal 2026 | $ | 9,558 | |||
| 2027 | 19,689 | ||||
| 2028 | 20,280 | ||||
| 2029 | 20,888 | ||||
| 2030 | 17,867 | ||||
| Total | $ | 88,282 | |||
| As of | |||||||||||
| April 30, 2026 | October 31, 2025 | ||||||||||
| (in thousands) | |||||||||||
| Cumulative currency translation adjustments | $ | (136,871) | $ | (137,457) | |||||||
| Unrealized gains (losses) on derivative instruments, net of taxes | (107,205) | (95,158) | |||||||||
| Unrealized gains (losses) on available-for-sale securities, net of taxes | (6) | 201 | |||||||||
| Total | $ | (244,082) | $ | (232,414) | |||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Reclassifications: | |||||||||||||||||||||||
| Gains (losses) on cash flow hedges, net of taxes | |||||||||||||||||||||||
| Revenues | $ | 1,085 | $ | 1,282 | $ | 2,275 | $ | 280 | |||||||||||||||
| Operating expenses | (3,346) | (3,069) | (4,864) | (5,655) | |||||||||||||||||||
Interest expense | (1,331) | (888) | (2,663) | (888) | |||||||||||||||||||
| Total | $ | (3,592) | $ | (2,675) | $ | (5,252) | $ | (6,263) | |||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
Shares repurchased | 640 | — | 640 | — | |||||||||||||||||||
Aggregate purchase price | $ | 262,500 | $ | — | $ | 262,500 | $ | — | |||||||||||||||
| Reissuance of treasury stock | 635 | 528 | 1,268 | 1,034 | |||||||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Cost of products | $ | 18,506 | $ | 23,050 | $ | 38,479 | $ | 43,527 | |||||||||||||||
| Cost of maintenance and service | 11,411 | 9,502 | 24,551 | 18,493 | |||||||||||||||||||
| Research and development expense | 110,694 | 109,717 | 233,909 | 212,413 | |||||||||||||||||||
| Sales and marketing expense | 51,150 | 36,700 | 111,717 | 71,650 | |||||||||||||||||||
| General and administrative expense | 30,542 | 22,754 | 72,371 | 42,103 | |||||||||||||||||||
Stock-based compensation expense before taxes | 222,303 | 201,723 | 481,027 | 388,186 | |||||||||||||||||||
| Income tax benefit | (33,768) | (32,659) | (73,068) | (62,847) | |||||||||||||||||||
| Stock-based compensation expense after taxes | $ | 188,535 | $ | 169,064 | $ | 407,959 | $ | 325,339 | |||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Expected life (in years) | 1.67 | 2.67 | 1.67 - 2.87 | 2.67 - 2.79 | |||||||||||||||||||
| Risk-free interest rate | 3.38 | % | 3.90 | % | 3.38% - 3.48% | 3.90% - 4.39% | |||||||||||||||||
| Volatility | 55.12 | % | 33.40 | % | 44.90% - 55.12% | 33.40% - 34.72% | |||||||||||||||||
Weighted average grant date fair value per share | $322.60 | $409.94 | $454.13 | $458.66 | |||||||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Intrinsic value of awards exercised | $ | 14,240 | $ | 34,479 | $ | 24,602 | $ | 54,837 | |||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands, except per share amounts) | |||||||||||||||||||||||
| Numerator: | |||||||||||||||||||||||
Net income from continuing operations attributed to Synopsys | $ | 17,105 | $ | 349,232 | $ | 82,063 | $ | 644,915 | |||||||||||||||
| Net loss from discontinued operations attributed to Synopsys | — | (3,900) | — | (3,900) | |||||||||||||||||||
| Net income attributed to Synopsys | $ | 17,105 | $ | 345,332 | $ | 82,063 | $ | 641,015 | |||||||||||||||
| Denominator: | |||||||||||||||||||||||
| Weighted average common shares for basic net income per share | 191,464 | 154,927 | 190,513 | 154,666 | |||||||||||||||||||
| Dilutive effect of common share equivalents from equity-based compensation | 680 | 1,161 | 1,067 | 1,552 | |||||||||||||||||||
| Weighted average common shares for diluted net income per share | 192,144 | 156,088 | 191,580 | 156,218 | |||||||||||||||||||
| Net income (loss) per share attributed to Synopsys - basic: | |||||||||||||||||||||||
Continuing operations | $ | 0.09 | $ | 2.25 | $ | 0.43 | $ | 4.17 | |||||||||||||||
Discontinued operations | — | (0.02) | — | (0.03) | |||||||||||||||||||
| Basic net income per share | $ | 0.09 | $ | 2.23 | $ | 0.43 | $ | 4.14 | |||||||||||||||
| Net income (loss) per share attributed to Synopsys - diluted: | |||||||||||||||||||||||
Continuing operations | $ | 0.09 | $ | 2.24 | $ | 0.43 | $ | 4.13 | |||||||||||||||
Discontinued operations | — | (0.03) | — | (0.03) | |||||||||||||||||||
| Diluted net income per share | $ | 0.09 | $ | 2.21 | $ | 0.43 | $ | 4.10 | |||||||||||||||
| Anti-dilutive employee stock-based awards excluded | 1,720 | 1,897 | 781 | 413 | |||||||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Total Segments: | |||||||||||||||||||||||
| Revenue | $ | 2,275,985 | $ | 1,604,266 | $ | 4,684,783 | $ | 3,059,581 | |||||||||||||||
Cost of revenue and operating expenses | 1,376,269 | 994,996 | 2,771,415 | 1,919,094 | |||||||||||||||||||
| Adjusted operating income | 899,716 | 609,270 | 1,913,368 | 1,140,487 | |||||||||||||||||||
| Adjusted operating margin | 40 | % | 38 | % | 41 | % | 37 | % | |||||||||||||||
| Design Automation: | |||||||||||||||||||||||
| Revenue | $ | 1,821,776 | $ | 1,122,235 | $ | 3,823,594 | $ | 2,142,451 | |||||||||||||||
Cost of revenue and operating expenses | 1,032,718 | 663,479 | 2,087,004 | 1,279,025 | |||||||||||||||||||
| Adjusted operating income | 789,058 | 458,756 | 1,736,590 | 863,426 | |||||||||||||||||||
| Adjusted operating margin | 43 | % | 41 | % | 45 | % | 40 | % | |||||||||||||||
| Design IP: | |||||||||||||||||||||||
| Revenue | $ | 454,209 | $ | 482,031 | $ | 861,189 | $ | 917,130 | |||||||||||||||
Cost of revenue and operating expenses | 343,551 | 331,517 | 684,411 | 640,069 | |||||||||||||||||||
| Adjusted operating income | 110,658 | 150,514 | 176,778 | 277,061 | |||||||||||||||||||
| Adjusted operating margin | 24 | % | 31 | % | 21 | % | 30 | % | |||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Total segment adjusted operating income | $ | 899,716 | $ | 609,270 | $ | 1,913,368 | $ | 1,140,487 | |||||||||||||||
| Reconciling items: | |||||||||||||||||||||||
Amortization of acquired intangible assets | (403,631) | (11,656) | (807,866) | (24,252) | |||||||||||||||||||
| Stock-based compensation expense | (222,303) | (201,723) | (481,027) | (388,186) | |||||||||||||||||||
| Restructuring charges | (115,894) | — | (234,176) | — | |||||||||||||||||||
Acquisition/divestiture related items | (23,649) | (39,571) | (39,241) | (100,252) | |||||||||||||||||||
| Deferred compensation plan | (13,813) | 20,106 | (27,586) | 468 | |||||||||||||||||||
| Total operating income | $ | 120,426 | $ | 376,426 | $ | 323,472 | $ | 628,265 | |||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Revenue: | |||||||||||||||||||||||
| United States | $ | 974,422 | $ | 649,299 | $ | 2,070,507 | $ | 1,260,009 | |||||||||||||||
| Europe | 378,077 | 194,843 | 845,110 | 348,514 | |||||||||||||||||||
| China | 240,402 | 157,506 | 451,485 | 331,454 | |||||||||||||||||||
| Korea | 265,418 | 257,595 | 512,034 | 507,980 | |||||||||||||||||||
| Other | 417,666 | 345,023 | 805,647 | 611,624 | |||||||||||||||||||
| Consolidated | $ | 2,275,985 | $ | 1,604,266 | $ | 4,684,783 | $ | 3,059,581 | |||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Interest income | $ | 12,885 | $ | 89,890 | $ | 30,319 | $ | 125,611 | |||||||||||||||
| Gains (losses) on assets related to deferred compensation plan | 13,813 | (20,106) | 27,586 | (468) | |||||||||||||||||||
| Foreign currency exchange gains (losses) | (1,542) | (178) | (7,369) | (115) | |||||||||||||||||||
| Loss on sale of strategic investments | — | (2,435) | — | (2,435) | |||||||||||||||||||
Gain on sale of building | — | 51,385 | — | 51,385 | |||||||||||||||||||
| Other, net | 7,058 | (4,455) | 20,400 | (9,460) | |||||||||||||||||||
| Total | $ | 32,214 | $ | 114,101 | $ | 70,936 | $ | 164,518 | |||||||||||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Income before income taxes | $ | 19,276 | $ | 396,191 | $ | 98,329 | $ | 687,308 | |||||||||||||||
| Provision for income taxes | $ | 2,408 | $ | 47,181 | $ | 16,745 | $ | 40,887 | |||||||||||||||
| Effective tax rate | 12.5 | % | 11.9 | % | 17.0 | % | 5.9 | % | |||||||||||||||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | |||||||
| Three Months Ended April 30, | Six Months Ended April 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
(in millions, except per share amounts) | |||||||||||||||||||||||
| Revenue | $ | 2,276.0 | $ | 1,604.3 | $ | 4,684.8 | $ | 3,059.6 | |||||||||||||||
| Cost of revenue | $ | 629.9 | $ | 318.3 | $ | 1,267.2 | $ | 588.3 | |||||||||||||||
| Operating expenses | $ | 1,525.7 | $ | 909.5 | $ | 3,094.1 | $ | 1,843.0 | |||||||||||||||
| Operating income | $ | 120.4 | $ | 376.4 | $ | 323.5 | $ | 628.3 | |||||||||||||||
| Net income from continuing operations attributed to Synopsys | $ | 17.1 | $ | 349.2 | $ | 82.1 | $ | 644.9 | |||||||||||||||
Net loss from discontinued operations attributed to Synopsys | $ | — | $ | (3.9) | $ | — | $ | (3.9) | |||||||||||||||
| Diluted net income (loss) per share attributed to Synopsys: | |||||||||||||||||||||||
| Continuing operations | $ | 0.09 | $ | 2.24 | $ | 0.43 | $ | 4.13 | |||||||||||||||
| Discontinued operations | $ | — | $ | (0.03) | $ | — | $ | (0.03) | |||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||
| Design Automation | $ | 1,821.8 | $ | 1,122.3 | $ | 699.5 | 62 | % | |||||||||||||||
| Design IP | 454.2 | 482.0 | (27.8) | (6) | % | ||||||||||||||||||
| Total | $ | 2,276.0 | $ | 1,604.3 | $ | 671.7 | 42 | % | |||||||||||||||
| Six months ended | |||||||||||||||||||||||
| Design Automation | $ | 3,823.6 | $ | 2,142.5 | $ | 1,681.1 | 78 | % | |||||||||||||||
| Design IP | 861.2 | 917.1 | (55.9) | (6) | % | ||||||||||||||||||
| Total | $ | 4,684.8 | $ | 3,059.6 | $ | 1,625.2 | 53 | % | |||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | $ | 945.6 | $ | 828.3 | $ | 117.3 | 14 | % | |||||||||||||||
| Percentage of total revenue | 42 | % | 52 | % | |||||||||||||||||||
| Six months ended | $ | 1,897.2 | $ | 1,656.6 | $ | 240.6 | 15 | % | |||||||||||||||
| Percentage of total revenue | 41 | % | 54 | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | $ | 546.3 | $ | 510.7 | $ | 35.6 | 7 | % | |||||||||||||||
| Percentage of total revenue | 24 | % | 32 | % | |||||||||||||||||||
| Six months ended | $ | 1,287.8 | $ | 878.8 | $ | 409.0 | 47 | % | |||||||||||||||
| Percentage of total revenue | 27 | % | 29 | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||
| Maintenance revenue | $ | 539.9 | $ | 117.8 | $ | 422.1 | 358 | % | |||||||||||||||
| Professional service and other revenue | 244.2 | 147.4 | 96.8 | 66 | % | ||||||||||||||||||
| Total | $ | 784.1 | $ | 265.2 | $ | 518.9 | 196 | % | |||||||||||||||
| Percentage of total revenue | 34 | % | 16 | % | |||||||||||||||||||
| Six months ended | |||||||||||||||||||||||
| Maintenance revenue | $ | 1,077.6 | $ | 235.0 | $ | 842.6 | 359 | % | |||||||||||||||
| Professional service and other revenue | 422.2 | 289.2 | 133.0 | 46 | % | ||||||||||||||||||
| Total | $ | 1,499.8 | $ | 524.2 | $ | 975.6 | 186 | % | |||||||||||||||
| Percentage of total revenue | 32 | % | 17 | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||
| Cost of products revenue | $ | 232.9 | $ | 216.2 | $ | 16.7 | 8 | % | |||||||||||||||
| Cost of maintenance and service revenue | 148.6 | 94.4 | 54.2 | 57 | % | ||||||||||||||||||
Amortization of acquired intangible assets | 248.4 | 7.7 | 240.7 | 3,126 | % | ||||||||||||||||||
| Total | $ | 629.9 | $ | 318.3 | $ | 311.6 | 98 | % | |||||||||||||||
| Percentage of total revenue | 28 | % | 20 | % | |||||||||||||||||||
| Six months ended | |||||||||||||||||||||||
| Cost of products revenue | $ | 475.3 | $ | 385.0 | $ | 90.3 | 23 | % | |||||||||||||||
| Cost of maintenance and service revenue | 295.3 | 187.0 | 108.3 | 58 | % | ||||||||||||||||||
| Amortization of acquired intangible assets | 496.6 | 16.3 | 480.3 | 2,947 | % | ||||||||||||||||||
| Total | $ | 1,267.2 | $ | 588.3 | $ | 678.9 | 115 | % | |||||||||||||||
| Percentage of total revenue | 27 | % | 19 | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | $ | 700.1 | $ | 554.0 | $ | 146.1 | 26 | % | |||||||||||||||
| Percentage of total revenue | 31 | % | 35 | % | |||||||||||||||||||
| Six months ended | $ | 1,415.1 | $ | 1,107.2 | $ | 307.9 | 28 | % | |||||||||||||||
| Percentage of total revenue | 30 | % | 36 | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | $ | 382.0 | $ | 215.0 | $ | 167.0 | 78 | % | |||||||||||||||
| Percentage of total revenue | 17 | % | 13 | % | |||||||||||||||||||
| Six months ended | $ | 778.4 | $ | 424.2 | $ | 354.2 | 83 | % | |||||||||||||||
| Percentage of total revenue | 17 | % | 14 | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | $ | 172.4 | $ | 136.5 | $ | 35.9 | 26 | % | |||||||||||||||
| Percentage of total revenue | 8 | % | 9 | % | |||||||||||||||||||
| Six months ended | $ | 355.2 | $ | 303.6 | $ | 51.6 | 17 | % | |||||||||||||||
| Percentage of total revenue | 8 | % | 10 | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | 155.3 | 4.0 | 151.3 | 3,783 | % | ||||||||||||||||||
| Percentage of total revenue | 7 | % | — | % | |||||||||||||||||||
| Six months ended | 311.3 | 8.0 | 303.3 | 3,791 | % | ||||||||||||||||||
| Percentage of total revenue | 7 | % | — | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | $ | (133.4) | $ | (94.3) | $ | (39.1) | 41 | % | |||||||||||||||
| Percentage of total revenue | (6) | % | (6) | % | |||||||||||||||||||
| Six months ended | $ | (296.1) | $ | (105.5) | $ | (190.6) | 181 | % | |||||||||||||||
| Percentage of total revenue | (6) | % | (3) | % | |||||||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||
| Interest income | $ | 12.9 | $ | 89.9 | $ | (77.0) | (86) | % | |||||||||||||||
| Gains (losses) on assets related to deferred compensation plan | 13.8 | (20.1) | 33.9 | (169) | % | ||||||||||||||||||
| Foreign currency exchange losses | (1.5) | (0.2) | (1.3) | 650 | % | ||||||||||||||||||
| Loss on sale of strategic investments | — | (2.4) | 2.4 | (100) | % | ||||||||||||||||||
Gain on sale of building | — | 51.4 | (51.4) | (100) | % | ||||||||||||||||||
| Other, net | 7.0 | (4.5) | 11.5 | (256) | % | ||||||||||||||||||
| Total | $ | 32.2 | $ | 114.1 | $ | (81.9) | (72) | % | |||||||||||||||
| Six months ended | |||||||||||||||||||||||
| Interest income | $ | 30.3 | $ | 125.6 | $ | (95.3) | (76) | % | |||||||||||||||
| Gains (losses) on assets related to deferred compensation plan | 27.6 | (0.5) | 28.1 | (5,620) | % | ||||||||||||||||||
| Foreign currency exchange losses | (7.4) | (0.1) | (7.3) | 7,300 | % | ||||||||||||||||||
| Loss on sale of strategic investments | — | (2.4) | 2.4 | (100) | % | ||||||||||||||||||
Gain on sale of building | — | 51.4 | (51.4) | (100) | % | ||||||||||||||||||
| Other, net | 20.4 | (9.5) | 29.9 | (315) | % | ||||||||||||||||||
| Total | $ | 70.9 | $ | 164.5 | $ | (93.6) | (57) | % | |||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||
| Adjusted operating income | $ | 789.1 | $ | 458.8 | $ | 330.3 | 72 | % | |||||||||||||||
| Adjusted operating margin | 43 | % | 41 | % | 2 | % | 5 | % | |||||||||||||||
| Six months ended | |||||||||||||||||||||||
| Adjusted operating income | $ | 1,736.6 | $ | 863.4 | $ | 873.2 | 101 | % | |||||||||||||||
| Adjusted operating margin | 45 | % | 40 | % | 5 | % | 13 | % | |||||||||||||||
| April 30, | |||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | ||||||||||||||||||||
| (dollars in millions) | |||||||||||||||||||||||
| Three months ended | |||||||||||||||||||||||
| Adjusted operating income | $ | 110.7 | $ | 150.5 | $ | (39.8) | (26) | % | |||||||||||||||
| Adjusted operating margin | 24 | % | 31 | % | (7) | % | (23) | % | |||||||||||||||
| Six months ended | |||||||||||||||||||||||
| Adjusted operating income | $ | 176.8 | $ | 277.1 | $ | (100.3) | (36) | % | |||||||||||||||
| Adjusted operating margin | 21 | % | 30 | % | (9) | % | (30) | % | |||||||||||||||
| Six Months Ended April 30, | |||||||||||||||||
| 2026 | 2025 | $ Change | |||||||||||||||
| (dollars in millions) | |||||||||||||||||
| Cash provided by operating activities | $ | 1,485.8 | $ | 207.9 | $ | 1,277.9 | |||||||||||
| Cash provided by (used in) investing activities | $ | (89.4) | $ | 54.0 | $ | (143.4) | |||||||||||
| Cash provided by (used in) financing activities | $ | (1,864.1) | $ | 9,954.6 | $ | (11,818.7) | |||||||||||
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | |||||||
| Item 4. | Controls and Procedures | |||||||
| Item 1. | Legal Proceedings | |||||||
| Item 1A. | Risk Factors | |||||||
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | |||||||
| Period | Total number of shares purchased(1) | Average price paid per share(1) | Total number of shares purchased as part of publicly announced programs(1) | Maximum approximate dollar value of shares that may yet be purchased under the programs(2) | ||||||||||||||||||||||
| Month #1 | ||||||||||||||||||||||||||
February 1, 2026 through February 28, 2026 | — | $ | — | — | $ | 2,000,000,000 | ||||||||||||||||||||
| Month #2 | ||||||||||||||||||||||||||
March 1, 2026 through March 31, 2026 | 605,380 | $ | 411.02 | 605,380 | $ | 1,713,677,459 | ||||||||||||||||||||
| Month #3 | ||||||||||||||||||||||||||
April 1, 2026 through April 30, 2026 | 34,560 | $ | 395.76 | 34,560 | $ | 1,700,000,097 | ||||||||||||||||||||
| Total | 639,940 | $ | 410.19 | 639,940 | $ | 1,700,000,097 | ||||||||||||||||||||
| Item 5. | Other Information | |||||||
| Item 6. | Exhibits | |||||||
| Exhibit Number | Incorporated By Reference | Filed Herewith | ||||||||||||||||||||||||||||||||||||
| Exhibit Description | Form | File No. | Exhibit | Filing Date | ||||||||||||||||||||||||||||||||||
| 3.1 | 10-Q | 000-19807 | 3.1 | 9/15/2003 | ||||||||||||||||||||||||||||||||||
| 3.2 | 8-K | 000-19807 | 3.1 | 3/25/2024 | ||||||||||||||||||||||||||||||||||
10.1* | 8-K | 000-19807 | 10.1 | 4/20/2026 | ||||||||||||||||||||||||||||||||||
10.2* | X | |||||||||||||||||||||||||||||||||||||
10.3* | X | |||||||||||||||||||||||||||||||||||||
10.4* | X | |||||||||||||||||||||||||||||||||||||
| 31.1 | X | |||||||||||||||||||||||||||||||||||||
| 31.2 | X | |||||||||||||||||||||||||||||||||||||
32.1+ | X | |||||||||||||||||||||||||||||||||||||
| Exhibit Number | Incorporated By Reference | Filed Herewith | ||||||||||||||||||||||||||||||||||||
| Exhibit Description | Form | File No. | Exhibit | Filing Date | ||||||||||||||||||||||||||||||||||
| 101 | The following financial statements from Synopsys' Quarterly Report on Form 10-Q for the quarter ended April 30, 2026, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of April 30, 2026 and October 31, 2025, (ii) Condensed Consolidated Statements of Income for the Three and Six Months Ended April 30, 2026 and April 30, 2025, (iii) Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended April 30, 2026 and April 30, 2025, (iv) Condensed Consolidated Statements of Stockholders' Equity at April 30, 2026 and April 30, 2025, (v) Condensed Consolidated Statements of Cash Flows for the Six Months Ended April 30, 2026 and April 30, 2025 and (vi) the Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags | X | ||||||||||||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||||||||||||||||||||||||||||||||
| SYNOPSYS, INC. | ||||||||
| Date: May 27, 2026 | By: | /s/ SHELAGH GLASER | ||||||
| Shelagh Glaser Chief Financial Officer (Principal Financial Officer) | ||||||||
| Participant: | |||||
| ID: | |||||
| Award Number: | |||||
| Date of Grant: | |||||
| [TIME-BASED FORM: | |||||
| Vesting Commencement Date: | |||||
| Number of Restricted Stock Units: | |||||
| [PERFORMANCE-BASED FORM: | |||||
| Target Number of Performance Restricted Stock Units: | |||||
| Maximum number of Performance Restricted Stock Units: | |||||
| Payment for Common Stock: | |||||
Vesting Schedule: | |||||
By signing this Notice and Agreement below or, in case this information is presented to you electronically, by clicking the “Accept” or similar button implemented into the relevant web page or platform, you declare, without limitation, your consent to the data processing operations described in this Notice and Agreement. You may withdraw your consent at any time with future effect for any or no reason as described in Section 12(e) above. | ||
SYNOPSYS, INC. | PARTICIPANT | ||||
By: ___________________________ | By:____________________________ | ||||
Title: _________________________ | Name:__________________________ | ||||
Date:__________________________ | Date:___________________________ | ||||
Eligible Director: | ||||||||
Grant Number: | ||||||||
Date of Grant: | ||||||||
Number of Shares Subject to Award: | ||||||||
Vesting Schedule: | |||||
COMPANY: | Synopsys, Inc. | |||||||
675 Almanor Ave | ||||||||
Sunnyvale, California 94085 | ||||||||
Attn: Shareholder Services | ||||||||
YOU: | Your address as on file with the Company at the time notice is given | |||||||
ESCROW AGENT: | Corporate Secretary | |||||||
Synopsys, Inc. | ||||||||
675 Almanor Ave | ||||||||
Sunnyvale, California 94085 | ||||||||
SYNOPSYS, INC. | ELIGIBLE DIRECTOR | |||||||||||||
By: | By: | |||||||||||||
Name: | Name: | |||||||||||||
Title: | General Counsel and Corporate Secretary | |||||||||||||
Date: | Date: | |||||||||||||
By: | |||||
Name: | |||||
Title: | |||||
| Lead Independent Director: | $30,000 | ||||
| Audit Committee Chair: | $40,000 | ||||
| Compensation and Organizational Development Committee Chair: | $25,000 | ||||
| Corporate Governance and Nominating Committee Chair: | $25,000 | ||||
| Audit Committee Member: | $15,000 | ||||
| Compensation and Organizational Development Committee Member: | $10,000 | ||||
| Corporate Governance and Nominating Committee Member: | $10,000 | ||||
| Date: May 27, 2026 | /s/ Sassine Ghazi | |||||||
| Sassine Ghazi President and Chief Executive Officer (Principal Executive Officer) | ||||||||
| Date: May 27, 2026 | /s/ Shelagh Glaser | |||||||
| Shelagh Glaser Chief Financial Officer (Principal Financial Officer) | ||||||||
| /s/ Sassine Ghazi | |||||
| Sassine Ghazi President and Chief Executive Officer | |||||
| /s/ Shelagh Glaser | |||||
| Shelagh Glaser Chief Financial Officer | |||||